Tanja Skyttä

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial

Alexander Eggermont, Christian U. Blank, Mario Mandalà et al. · The Lancet Oncology · 2021 · 389 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer

Orit Kaidar‐Person, Birgitte Vrou Offersen, S. Hol et al. · Radiotherapy and Oncology · 2019 · 137 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy

Tanja Skyttä, Suvi Tuohinen, Eeva Boman et al. · Radiation Oncology · 2015 · 134 citations · Full text

Medicine, Oncology, Radiation Oncology +17

AlignRT^® and Catalyst™ in whole‐breast radiotherapy with DIBH: Is IGRT still needed?

Marko Laaksomaa, Sebastian Sarudis, M Rossi et al. · Journal of Applied Clinical Medical Physics · 2019 · 102 citations · Full text

Medicine, Oncology, Radiation Oncology +16

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations

Icro Meattini, Carlotta Becherini, Saverio Caini et al. · The Lancet Oncology · 2024 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +16